← Leaderboards
Robert F Balint
Panorama Research, Inc.
$2,810,686
Attributed
$2,810,686
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $449.5K · FY2006–14$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,810,686 · 9
By mechanism
R43$2,060,686 · 8
R44$750,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Panorama Research, Inc.
Same institution · by research overlap
- James W Larrick$19,609,694
- K Jin Kim$2,694,894
- David S Wilson$329,606
- Andrew R Mendelsohn$3,743,233
- Taruna Arora$112,491
Others in their field
Top investigators on “Escherichia Coli”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Scott J Hultgren · Washington University$41,419,179
- John L Markley · University Of Wisconsin Madison$37,032,573
- Wilhelmus G. J. Hol · University Of Washington$31,124,692
- Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
- Peter D Karp · Sri International$27,278,650
Research focus
Escherichia ColiAntigensSensorProtein EngineeringDosePhenotypeBaseLibrariesEngineeringSerine ProteaseCleaved CellCellsAntibodiesValidationVariantSafetyClinicMonoclonal AntibodiesKineticsGaliumAntibody AffinityImmunogenicityEnzymesFamily
Grant awards (12)
HUMAN PROTEOLYTIC FOR IgA NEPHROPATHY$99,916
R43 · FY2014 · AI · contact PI
HUMAN PROTEOLYTIC FOR IgA NEPHROPATHY$299,749
R43 · FY2013 · AI · contact PI
ENGINEERING THERAPEUTIC PROTEASES$97,919
R43 · FY2012 · AI · contact PI
ENGINEERING THERAPEUTIC PROTEASES$299,750
R43 · FY2011 · AI · contact PI
PROTEOLYTIC ANTIBODIES FOR TREATMENT OF PSORIASIS$299,750
R43 · FY2009 · AI · contact PI
PROTEOLYTIC ANTIBODIES FOR BIODEFENSE$300,000
R43 · FY2008 · AI · contact PI
HOMOGENEOUS ASSAY PLATFORM FOR CLINICAL DIAGNOSTICS$149,522
R43 · FY2008 · GM · contact PI
Novel Strategies for Selection of Anti-GPCR Antibodies$299,600
R43 · FY2006 · AI · contact PI
STABLE FOLD SELECTION FOR HETEROLOGOUS PROTEINS$375,000
R44 · FY2001 · AI
SIGNAL TRANSDUCTION BIOSENSORS FOR ANTI-CANCER HTS$100,000
R43 · FY2001 · CA
STABLE FOLD SELECTION FOR HETEROLOGOUS PROTEINS$375,000
R44 · FY2000 · AI
TUMOR-ACTIVATED ENZYME PRODRUG THERAPY (TACEPT)$114,480
R43 · FY2000 · CA